Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost
Clinical trial NCT00348400 · COMPLETED
Trial details
- NCT number
- NCT00348400
- Sponsor
- Innovative Medical
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.